Skip to main content
Caplight Logo









Curenetics

Curenetics

Private
LondonHealthcare & Life Scienceshttps://www.curenetics.io/

Last Round

Accelerator

Apr 14, 2026

Total Funding Raised

$140,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Curenetics is a healthcare technology company that provides an AI-driven precision oncology platform designed to predict patient response to immunotherapy treatments.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Healthcare Analytics, Medical Imaging, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

precision oncologymedical AIimmunotherapy responsecancer diagnosticsclinical decision supportdigital pathologygenomic analysispatient stratificationmultimodal AIbiotech softwarecontract research organizationCROAI-driven diagnosticscomputational oncologyAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curenetics Comparables

Compare Curenetics with similar companies based on industry and business-model similarity.

Curenetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VieCure
77%
BostonGene
76%
SOPHiA GENETICS
69%

Curenetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 14, 2026
GrantOct 6, 2023

Key People

Founding team and executive leadership

Sola Adeleke

Founder CMO

Founding Team

Curenetics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Grew 28% QoQ, from 18 to 23 employees.

  • Apr 14, 2026

    $140K raised from National Quantum Computing Centre and STFC.

Curenetics Filings

Explore SEC and related filing metadata, where available.

Curenetics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Curenetics's valuation, stock price, and market status.

Is Curenetics a public or private company?

Curenetics is a private company.

What is the current stock price of Curenetics?

Curenetics is a private company with no public stock price. No recent secondary market data is available.

How much is Curenetics worth (valuation)?

Valuation information for Curenetics is not publicly available.

Can I buy Curenetics stock?

Curenetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Curenetics's last funding round?

Curenetics's most recent funding round was Accelerator on April 14, 2026.

Who are the main investors in Curenetics?

Key investors in Curenetics include National Quantum Computing Centre, Science and Technology Facilities Council, National Institute for Health and Care Research.

Will Curenetics IPO soon?

No public IPO plans have been announced for Curenetics.

How can I track Curenetics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curenetics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range14
Year Founded2018
Last FundingApr 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?